Insider Selling: Astera Labs (NASDAQ:ALAB) COO Sells 90,459 Shares of Stock

Astera Labs, Inc. (NASDAQ:ALAB) COO Sanjay Gajendra sold 90,459 shares of Astera Labs stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $13,088,512.71. Following the completion of the sale, the chief operating officer owned 1,599,750 shares of the company’s stock, valued at $231,467,827.50. This trade represents a 5.35% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Sanjay Gajendra also recently made the following trade(s):

• On Monday, November 17th, Sanjay Gajendra sold 90,459 shares of Astera Labs stock. The stock was sold at an average price of $144.69, for a total transaction of $13,088,512.71.

Astera Labs Stock Performance

Astera Labs stock traded up $2.49 during trading on Wednesday, reaching $142.01. The company had a trading volume of 4,125,472 shares, compared to its average volume of 5,263,438. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90. The stock’s 50 day moving average price is $190.50 and its two-hundred day moving average price is $145.33. The firm has a market capitalization of $23.99 billion, a price-to-earnings ratio of 127.94, a PEG ratio of 2.64 and a beta of 1.37.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The company had revenue of $230.58 million for the quarter, compared to analyst estimates of $206.42 million. During the same quarter last year, the business earned $0.23 EPS. Astera Labs’s revenue for the quarter was up 103.9% on a year-over-year basis. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, research analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Hedge Funds Weigh In On Astera Labs

A number of institutional investors and hedge funds have recently bought and sold shares of ALAB. Fred Alger Management LLC boosted its stake in shares of Astera Labs by 13.0% in the first quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company’s stock valued at $93,087,000 after purchasing an additional 179,638 shares during the period. Hoey Investments Inc. increased its stake in Astera Labs by 22.4% during the 2nd quarter. Hoey Investments Inc. now owns 6,121 shares of the company’s stock worth $553,000 after buying an additional 1,121 shares during the period. Sumitomo Mitsui Trust Group Inc. lifted its holdings in Astera Labs by 21.6% in the 2nd quarter. Sumitomo Mitsui Trust Group Inc. now owns 14,781 shares of the company’s stock worth $1,336,000 after buying an additional 2,624 shares in the last quarter. Wealth Effects LLC purchased a new position in Astera Labs in the 2nd quarter valued at about $242,000. Finally, Maryland State Retirement & Pension System grew its stake in shares of Astera Labs by 37.7% during the second quarter. Maryland State Retirement & Pension System now owns 6,960 shares of the company’s stock valued at $629,000 after acquiring an additional 1,906 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Analyst Ratings Changes

ALAB has been the subject of several research analyst reports. Northland Capmk upgraded Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Monday. JPMorgan Chase & Co. boosted their target price on Astera Labs from $180.00 to $215.00 and gave the stock an “overweight” rating in a report on Wednesday, November 5th. Deutsche Bank Aktiengesellschaft raised their price target on shares of Astera Labs from $160.00 to $200.00 and gave the company a “buy” rating in a report on Tuesday, September 2nd. Wall Street Zen cut shares of Astera Labs from a “buy” rating to a “hold” rating in a research report on Tuesday, November 11th. Finally, Stifel Nicolaus increased their price objective on shares of Astera Labs from $185.00 to $200.00 and gave the stock a “buy” rating in a research report on Wednesday, November 5th. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and an average target price of $184.82.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.